These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20508898)

  • 1. Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen gammaArg275His mutation (fibrinogen Zabrze).
    Undas A; Pastuszczak M; Iwaniec T; Kapelak K; Neerman-Arbez M
    Thromb Haemost; 2010 Aug; 104(2):415-7. PubMed ID: 20508898
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
    Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553
    [No Abstract]   [Full Text] [Related]  

  • 3. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
    Castaman G; Giacomelli SH; Duga S; Rodeghiero F
    Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
    [No Abstract]   [Full Text] [Related]  

  • 4. Three cases of abnormal fibrinogens: sumperk (Bbeta His67Leu), Unicov (Bbeta Gly414Ser), and Brno (gammaArg275His).
    Kotlín R; Reicheltová Z; Sobotková A; Suttnar J; Salaj P; Pospísilová D; Smejkal P; Chrastinová L; Dyr JE
    Thromb Haemost; 2008 Dec; 100(6):1199-200. PubMed ID: 19132250
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
    Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two novel mutations in the fibrinogen γ nodule.
    Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
    Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
    Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genotype and function analyses of four inherited dysfibrinogenemia pedigree caused by Arg16 amino acid substitution in fibrinogen Aα chain].
    Jiang LL; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):475-9. PubMed ID: 22967385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional study of abnormal fibrinogen caused by Arg275His mutation in fibrinogen γ chain].
    Zhou JY; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):190-4. PubMed ID: 23683413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel FGG variant (γ339C→S) confirms importance of the γ326-339 disulphide bond for plasma expression of newly synthesised fibrinogen.
    Brennan SO; Laurie A; Smith M
    Thromb Haemost; 2015 Apr; 113(4):903-5. PubMed ID: 25588350
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
    Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
    Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
    Vorjohann S; Fish RJ; Biron-Andréani C; Nagaswami C; Weisel JW; Boulot P; Reyftmann L; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2010 Nov; 104(5):990-7. PubMed ID: 20806111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
    Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
    Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
    Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
    Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
    Westbury SK; Duval C; Philippou H; Brown R; Lee KR; Murden SL; Phillips E; Reilly-Stitt C; Whalley D; Ariëns RA; Mumford AD
    Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis.
    Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
    Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE
    Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
    Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P
    J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
    Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
    Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.